Top Abstract Purchase Related
Home
>
Node
>
Subnode

The combined magnetoradiotherapy of breast cancer

Akhmetov, E.D.; Liu, B.N.; Dzhamaldinov, D.D.; Musin, T.B.; Ismailov, B.I.

Voprosy Onkologii 38(7): 823-828

1992

ISSN/ISBN: 0507-3758
PMID: 1300786
Document Number: 399169
Preoperative magnetoradiation therapy of stage II-III breast cancer patients was followed by pronounced regression of tumor and axillary lymph node metastases in all cases. The treatment modality had been previously substantiated by establishing the optimal sequence and time intervals for magnetic and radiation fields. Complete regression of primary tumor and metastases verified by histologic and cytologic examination of surgical and biopsy material was observed in 20%. The best results were obtained for edematous-infiltrative form of cancer. In the control group (radiation alone), regression of tumor was only slight, nor did lymph node metastases regress. Magnetoradiation therapy did not involve either immediate or delayed adverse side-effects.

Document emailed within 1 workday
Secure & encrypted payments

Steinberg, J.L.; Trudeau, M.E.; Ryder, D.E.; Fishell, E.; Chapman, J.A.; McCready, D.R.; Fish, E.B.; Hiraki, G.Y.; Ross, T.M.; Lickley, L.A. 1996: Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 39(4): 302-311
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Novotná, L.; Bergsteinová, V. 1981: Survival after combined therapy of breast cancer Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 60(6): 389-394
Lynch, H.T.; Krush, A.J.; Guirgis, H. 1973: Genetic factors in families with combined gastrointestinal and breast cancer American Journal of Gastroenterology 59(1): 31-40
Lányi, M.; László, G.; Farkas, M. 1970: Combined clinical and mammographic mass screening in breast cancer Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 11(1): 18-26
Ono, K.; Danura, T.; Koyama, Y.; Hidaka, H. 2005: Combined use of paravertebral block and general anesthesia for breast cancer surgery Masui. Japanese Journal of Anesthesiology 54(11): 1273-1276
Sanchakova, A.V. 1972: Combined and complex treatment of diffuse-infiltrative forms of breast cancer Voprosy Onkologii 18(4): 6-10
Sakurai, K.; Matsuo, S.; Enomoto, K.; Amano, S.; Shiono, M. 2009: The combined effect of paclitaxel and toremifene therapy for metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 1994-1996
Korman, D.B.; Borisov, A.I.; Maslova, I.A.; Dobroskok, L.B. 1980: Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases Voprosy Onkologii 26(8): 20-24
Pannuti, F.; Martoni, A.; Piana, E.; Tomasi, L.; Grieco, A.; Farris, A.; Saccani, F.; Baroni, M. 1984: Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(4): 211-215
Mangkharak, J.; Patanachak, C.; Podhisuwan, K.; Pleehachinda, R. 1997: The evaluation of combined scintimammography and tumor markers in breast cancer patients Anticancer Research 17(3B): 1611-1614
Cowan, K.; Lippman, M. 1981: Recent progress in breast cancer management. Combined modality (adjuvant) therapy Archives of Internal Medicine 141(8): 1055-1059
Velikaya, V.V.; Musabaeva, L.I.; Startseva, Z.A.; Lisin, V.A. 2015: Fast neutrons 6.3 MeV in the combined treatment of patients with local recurrence of breast cancer Voprosy Onkologii 61(4): 583-585
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Sica, G.; Lama, G.; Iacopino, F.; Angelucći, C.; Della Cuna, G.R.; Marchetti, P. 1991: Antitumor effect of lonidamine alone or combined with tamoxifen or medroxyprogesterone acetate in breast cancer cells Anticancer Research 11(6): 2099-2102
Elamin, M.H.; Elmahi, A.B.; Daghestani, M.H.; Al-Olayan, E.M.; Al-Ajmi, R.A.; Alkhuriji, A.F.; Hamed, S.S.; Elkhadragy, M.F. 2019: Synergistic Anti-Breast-Cancer Effects of Combined Treatment with Oleuropein and Doxorubicin in Vivo Alternative Therapies in Health and Medicine 25(3): 17-24
Ma, C.; Li, L.X.; Zhang, Y.; Xiang, C.; Ma, T.; Ma, Z.Q.; Zhang, Z.P. 2015: Protective and sensitive effects of melatonin combined with adriamycin on ER+ (estrogen receptor) breast cancer European Journal of Gynaecological Oncology 36(2): 197-202
Swain, S.M.; Sorace, R.A.; Bagley, C.S.; Danforth, D.N.; Bader, J.; Wesley, M.N.; Steinberg, S.M.; Lippman, M.E. 1987: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer Cancer Research 47(14): 3889-3894
Korman, D.B.; Maslova, I.A.; Borisov, A.I. 1982: Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases Voprosy Onkologii 28(8): 14-19
Ciatto, S.; Ambrogetti, D.; Muraca, M.G. 1995: Combined diagnosis of breast cancer recurrences after conservative treatment. Critical review of 143 consecutive cases La Radiologia Medica 90(4): 383-385